Skip to content
Open access

Joint associations of lipoprotein(a) and systemic inflammatory indices with FibroTouch-derived hepatic steatosis and liver stiffness in Chinese adults

Aug 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 47 references
Medicine

TL;DR

Among Chinese adults, higher circulating Lp(a) was inversely associated with FibroTouch-derived hepatic steatosis and liver stiffness and combining Lp(a) with systemic inflammatory indices may provide complementary information for noninvasive cross-sectional assessment.

Abstract

Background Lipoprotein(a) [Lp(a)] is synthesized mainly in the liver, whereas blood cell-derived inflammatory indices reflect systemic immune–inflammatory status. We examined their associations with FibroTouch-assessed hepatic steatosis and liver stiffness in Chinese adults. Methods This hospital-based cross-sectional study included 1,345 Chinese adults. Nonalcoholic fatty liver disease (NAFLD) was defined as controlled attenuation parameter (CAP) ≥248 dB/m, and elevated liver stiffness as liver stiffness measurement (LSM) ≥8 kPa. Multivariable logistic and linear regression, restricted cubic spline (RCS), receiver operating characteristic (ROC), joint-exposure, subgroup, and sensitivity analyses were performed. Results Higher Lp(a) quartiles were associated with lower prevalences of NAFLD and elevated liver stiffness and with lower CAP and LSM values. After full adjustment, the highest versus lowest quartile was associated with lower odds of NAFLD (odds ratio [OR], 0.28; 95% confidence interval [CI], 0.20–0.41) and elevated liver stiffness (OR, 0.31; 95% CI, 0.21–0.45). RCS analyses showed significant inverse associations without evidence of nonlinearity. Higher Lp(a) was also associated with lower CAP (β, −14.40; 95% CI, −17.79 to −11.01) and LSM (β, −0.58; 95% CI, −0.83 to −0.33). The Lp(a)–systemic immune-inflammation index (SII) combination showed the highest discrimination for NAFLD, whereas Lp(a)–systemic inflammation response index (SIRI) performed best for elevated liver stiffness. When added to the fully adjusted model, the corresponding areas under the ROC curve (AUCs) were 0.762 and 0.811, respectively, and exceeded those of established noninvasive fibrosis scores. Low Lp(a) combined with high inflammatory burden was associated with the highest odds of both outcomes. Conclusions Among Chinese adults, higher circulating Lp(a) was inversely associated with FibroTouch-derived hepatic steatosis and liver stiffness. Combining Lp(a) with systemic inflammatory indices may provide complementary information for noninvasive cross-sectional assessment.

Read PDF

Similar papers

Open access Aug 2026

Triglyceride-to-HDL Cholesterol Ratio is Associated with Hepatic Steatosis but not Fibrosis in Patients with Severe Obesity: A Cross-Sectional Study

Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with severe obesity. The triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) is an accessible surrogate marker of insulin resistance, but its association with hepatic steatosis and fibrosis in candid...

Carolina de Oliveira Bernardes, Esdras Marques Lins, Fernanda Appolônio Rocha et al. · 0 citations
Open access Aug 2026

Association Between the GGT/HDL-C Ratio and Ultrasonography-Defined NAFLD in Vietnamese Adults: A Cross-Sectional Study

The GGT/HDL-C ratio showed a significant unadjusted association with NAFLD and moderate discriminatory performance, however, because the association was no longer significant after full adjustment, it should currently be considered a simple laboratory-based screening marker that requires further validation before routi...

Truc-Mai T. Nguyen, H. T. Lam, T. D. Vo · 0 citations
Open access Aug 2026

Lipid Profiles in Liver Steatosis and Liver Fibrosis in Patients with Type 2 Diabetes and Coronary Artery Disease

Patients with T2DM, cardiovascular disease, and blood-based indices suggesting liver steatosis or fibrosis differed significantly with respect to the lipid profile, and an elevated HSI score, suggesting steatosis, was associated with dyslipidemia, and an elevated NFS score, suggesting fibrosis, was not.

Laura A. M. Konings, Weiwei Xu, Vivian D. de Jong et al. · 0 citations
Open access Sep 2026

Association between atherogenic index of plasma and metabolic dysfunction-associated steatotic liver disease in Egyptian population: a case–control study

Alyrogenic index of plasma is independently and positively associated with MASLD, more degree of hepatic steatosis, insulin resistance and low adiponectin level, and using AIP alone or in combination with BMI could alarm clinicians to further investigate for presence of MASLD in individuals at outpatient clinics.

Manal Abdel-Mageed, Marium M. Shamaa, M. Labane et al. · 0 citations
Aug 2026

Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study.

Higher VAI values are associated with MASLD in patients with T1DM, however, waist circumference outperforms VAI in identifying MASLD, suggesting that VAI may serve as a complementary marker of metabolic dysfunction rather than a standalone screening tool for MASLD in this patient population.

A. Mantovani, I. Milani, R. Morandin et al. · 0 citations
Open access Oct 2026

Neutrophil-to-lymphocyte ratio (NLR) in relation to metabolic profile and dietary antioxidant quality in adults with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a common metabolic condition characterized by hepatic steatosis and chronic low-grade inflammation, with oxidative stress playing a pivotal role in its progression. The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an accessible marker reflecting systemic inflamm...

Amr A. El-Sehrawy, Ahmed M. Salah, Ismail Kandil et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.